Precision Targeting of Microglia: Unlocking New Frontiers with TMEM119-CreERT2 Mouse Models for Preclinical Research
As the "immune sentinels" of the brain, microglia are masters of multitasking. From pruning synapses and shaping neural networks during development to clearing pathogens and responding to neurodegenerative disturbances, their roles are vast and complex [1-2].
However, for researchers, this complexity presents a challenge: how to unambiguously distinguish resident microglia from infiltrating peripheral macrophages—and manipulate them with both spatial and temporal precision.
To unlock the therapeutic potential of these cells, the field needs a "master key." TMEM119 is rapidly becoming the gold standard for specific microglial targeting.
1. Precision Microglia Targeting: How TMEM119-CreERT2 Revolutionizes CNS Immune Research
TMEM119 is widely recognized as a highly specific marker of parenchymal microglia. Transcriptomic and protein-level studies demonstrate that Tmem119 is abundantly expressed in CNS-resident microglia, but absent from bone-marrow-derived infiltrating macrophages [4]. This distinction is critical in neuroinflammatory and neurodegenerative contexts, where these myeloid populations coexist but perform fundamentally different functions.
Although TMEM119 expression can be dynamically regulated—and even downregulated—under certain pathological conditions, its specificity in homeostatic microglia remains unmatched, making it a powerful lineage and functional marker [5].
Figure 1: Microglial functions in the CNS [3].
2. The Molecular Identity Card: Distinguishing Resident Microglia from Infiltrating Macrophages
Importantly, TMEM119 is not merely a static label. In Alzheimer's disease (AD) models, its expression is significantly altered. Recent work demonstrates that microglial TMEM119 can directly bind amyloid-β and promote its clearance, leading to improved cognitive performance in AD mouse models [6]. These findings position TMEM119 as a potential therapeutic entry point, not just a descriptive marker.
3. Beyond a Specific Marker: TMEM119 as a Functional Node in Alzheimer's Disease Biology
Interestingly, the utility of Tmem119 extends beyond neuroscience:
Bone Biology: It acts as an osteoblast induction factor, promoting the differentiation of myoblasts into osteoblasts and participating in bone remodeling [7-8].
Oncology: In osteosarcoma, it may function as an oncogene, with expression levels correlating with tumor progression [9].
Reproductive Biology: It plays a critical role in testicular development and spermatogenesis [10].
4. Extra-Neural Roles of TMEM119: Expanding Relevance in Bone Biology, Oncology, and Reproduction
To translate these discoveries into in vivo insights, Cyagen has developed the Tmem119-CreERT2 mouse model—a precision genetic tool designed for microglia-specific, inducible gene manipulation.
We integrate a Tamoxifen-inducible CreERT2 recombinase element exactly at the stop codon of the murine Tmem119 gene. This strategy ensures that Cre expression faithfully mimics the endogenous expression pattern of TMEM119.
How it works: When crossed with mice containing loxP sites, the administration of Tamoxifen induces Cre-mediated recombination specifically in TMEM119-positive cells. This allows for precise, temporally controlled gene deletion or overexpression in resident microglia.
Validation Data
To confirm specificity, Cyagen crossed Tmem119-CreERT2 mice with a Rosa26-LSL-tdTomato reporter strain. Following Tamoxifen induction, brain tissues were analyzed via immunofluorescence (IF).
Figure 2. Expression of Cre recombinase in the hippocampus following Tamoxifen induction.
Figure 3. Expression of Cre recombinase in the cerebral cortex following Tamoxifen induction.
Validation of Microglia-Specific Cre Activity in Hippocampus and Cerebral Cortex: Histological analysis confirmed Cre-mediated recombination was restricted to microglia, with no detectable activity in neurons, astrocytes, or infiltrating immune cells.
Results: Histological analysis (G1-G4) revealed robust green fluorescence signals in both the hippocampus and cerebral cortex, indicating successful Cre recombination. Crucially, the red fluorescence (reporter) largely co-localized with green fluorescence in IBA1+ microglia, confirming that the model effectively targets the intended cell population.
5. TMEM119-CreERT2 Mouse Models: Achieving Spatial Specificity and Inducible Temporal Control
Whether you are investigating the nuances of neuroinflammation, exploring novel AD therapies, or studying bone development, the Tmem119-CreERT2 mouse provides the specificity and temporal control required for high-impact research.
Interested in adding this model to your pipeline? Follow Cyagen for more updates on our catalog of next-generation research models.
6. Conclusion
The TMEM119-CreERT2 mouse model represents a significant advancement in microglia research tools. By combining the specificity of the Tmem119 locus with the temporal control of CreERT2, researchers can now perform precise genetic manipulations in microglia without affecting other myeloid populations. This model opens new possibilities for understanding microglial biology and developing targeted therapies for neurological disorders.
7. References
[1] Colonna M, Butovsky O. Microglia Function in the Central Nervous System During Health and Neurodegeneration. Annu Rev Immunol. 2017 Apr 26;35:441-468.
[2] Kaiser T, Feng G. Tmem119-EGFP and Tmem119-CreERT2 Transgenic Mice for Labeling and Manipulating Microglia. eNeuro. 2019 Aug 26;6(4):ENEURO.0448-18.2019.
[3] Bobotis BC, Halvorson T, Carrier M, Tremblay MÈ. Established and emerging techniques for the study of microglia: visualization, depletion, and fate mapping. Front Cell Neurosci. 2024 Feb 15;18:1317125.
[4] Bennett ML, Bennett FC, Liddelow SA, Ajami B, Zamanian JL, Fernhoff NB, Mulinyawe SB, Bohlen CJ, Adil A, Tucker A, Weissman IL, Chang EF, Li G, Grant GA, Hayden Gephart MG, Barres BA. New tools for studying microglia in the mouse and human CNS. Proc Natl Acad Sci U S A. 2016 Mar 22;113(12):E1738-46.
[5] Ma W, Oswald J, Rios Angulo A, Chen Q. Tmem119 expression is downregulated in a subset of brain metastasis-associated microglia. BMC Neurosci. 2024 Feb 2;25(1):6.
[6] Liu J, Wang Z, Liang W, Zhang Z, Deng Y, Chen X, Hou Z, Xie Y, Wang Q, Li Y, Bai C, Li D, Mo F, Wang H, Wang D, Yuan J, Wang Y, Teng ZQ, Hu B. Microglial TMEM119 binds to amyloid-β to promote its clearance in an Aβ-depositing mouse model of Alzheimer's disease. Immunity. 2025 Jul 8;58(7):1830-1846.e7.
[7] Kawao N, Matsumura D, Yamada A, Okumoto K, Ohira T, Mizukami Y, Hashimoto D, Kaji H. Tmem119 is involved in bone anabolic effects of PTH through enhanced osteoblastic bone formation in mice. Bone. 2024 Apr;181:117040.
[8] Yamada A, Kawao N, Mizukami Y, Kaji H. Roles of Transmembrane Protein 119 in the Effects of Transforming Growth Factor-β on Mouse Bone Cells. Exp Clin Endocrinol Diabetes. 2025 May;133(5):246-252.
[9] Jiang ZH, Peng J, Yang HL, Fu XL, Wang JZ, Liu L, Jiang JN, Tan YF, Ge ZJ. Upregulation and biological function of transmembrane protein 119 in osteosarcoma. Exp Mol Med. 2017 May 12;49(5):e329.
[10] Mizuhashi K, Chaya T, Kanamoto T, Omori Y, Furukawa T. Obif, a Transmembrane Protein, Is Required for Bone Mineralization and Spermatogenesis in Mice. PLoS One. 2015 Jul 24;10(7):e0133704.
